Current Target Information
| HUGO ID | 6871 |
|---|---|
| Symbol | MAPK1 |
| Name | mitogen-activated protein kinase 1 |
| #Occurrence | 38 |
| #Paper | 9 |
| PMID | TITLE | # of Targets | Links | Journal |
|---|---|---|---|---|
| 16104843 | The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. | 64 | | Clin Sci (Lond) |
| 17191135 | Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. | 60 | | Neurochem Res |
| 16647138 | Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: their role and involvement in neurological disorders. | 59 | | Brain Res Rev |
| 18464925 | Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists. | 35 | | PPAR Res |
| 14739060 | Neurodegenerative diseases and oxidative stress. | 33 | | Biomed Pharmacother |
| 17582695 | Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides? | 21 | | Med Hypotheses |
| 17997855 | Expression of a Cu,Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of neuroblastoma cells to infectious injury. | 14 | | BMC Infect Dis |
| 18312546 | Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis. | 8 | | Neuropathology |
| 12060810 | Minocycline delays disease onset and mortality in a transgenic model of ALS. | 7 | | Neuroreport |